Lesinurad - Global and China Top Players Market Share and Ranking 2023
Lesinurad, also known as RDEA594, is a selective uric acid re-absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body.
This report studies and analyses global Lesinurad status and future trends, helps the client to determine the Lesinurad market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Lesinurad, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Lesinurad market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Lesinurad sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Lesinurad sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Lesinurad key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Lesinurad key producing regions, capacity, production, and year over year growth
(6) Lesinurad industry chains, upstream, midstream and downstream
According to Latest Research, the global market for Lesinurad should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Lesinurad market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Lesinurad market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Research Institute grew percent to account for percent of the total market sales, and Pharmaceutical grew percent.
Key Players Driving the Market:
AbMole BioScience
Ausun Pharmaceutical
Cayman Chemical
MedKoo Biosciences
Clearsynth
Target Mol
UQUIFA
MSN Labs
CHEMO
Nifty Labs
Manus Aktteva Biopharma LLP
Vcare Pharmatech
Meso Chem
By Product Type, the market is primarily segmented into:
Purity ≥ 98 %
Purity ≥ 99 %
By Applications, the market is segmented into:
Research Institute
Pharmaceutical
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Lesinurad product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Lesinurad market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Lesinurad market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Lesinurad, percent & CAGR, 2018-2029
Chapter 5: Lesinurad industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Lesinurad Definition
1.2 Global Lesinurad Market Size and Forecast
1.2.1 By Consumption Value, Global Lesinurad Market Size，2018-2029
1.2.2 By Sales Quantity, Global Lesinurad Market Size，2018-2029
1.2.3 Global Lesinurad Average Selling Price (ASP)，2018-2029
1.3 China Lesinurad Market Size and Forecast
1.3.1 By Consumption Value, China Lesinurad Market Size，2018-2029
1.3.2 By Sales Quantity, China Lesinurad Market Size，2018-2029
1.3.3 China Lesinurad Average Selling Price (ASP)， 2018-2029
1.4 Share of China Lesinurad Market with Respect to the Global Market
1.4.1 By Consumption Value, China Lesinurad Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Lesinurad Market Share in Global, 2018-2029
1.4.3 Lesinurad Market Size: China VS Global, 2018-2029
1.5 Lesinurad Market Dynamics
1.5.1 Lesinurad Market Drivers
1.5.2 Lesinurad Market Restraints
1.5.3 Lesinurad Industry Trends
1.5.4 Lesinurad Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Lesinurad, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Lesinurad, Global Market Share by Company, 2018-2023
2.3 Lesinurad Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Lesinurad Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Lesinurad Concentration Ratio
2.6 Global Lesinurad Mergers & Acquisitions, Expansion Plans
2.7 Global Lesinurad Manufacturers Product Type
2.8 Head Office and Lesinurad Production Site of Key Manufacturer
2.9 Lesinurad Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Lesinurad, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Lesinurad, China Market Share by Company, 2018-2023
3.3 China Lesinurad Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Lesinurad Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Lesinurad Capacity by Region
4.3 Global Lesinurad Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Lesinurad Production by Region, 2018-2029
4.5 Global Lesinurad Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Lesinurad Industry Chain
5.2 Lesinurad Upstream Analysis
5.2.1 Lesinurad Core Raw Materials
5.2.2 Main Manufacturers of Lesinurad Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lesinurad Production Mode
5.6 Lesinurad Procurement Model
5.7 Lesinurad Industry Sales Model and Sales Channels
5.7.1 Lesinurad Sales Model
5.7.2 Lesinurad Typical Distributors
6 Sights by Type
6.1 Lesinurad Classification
6.1.1 Purity ≥ 98 %
6.1.2 Purity ≥ 99 %
6.2 By Type, Global Lesinurad Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Lesinurad Consumption Value, 2018-2029
6.4 By Type, Global Lesinurad Sales Quantity, 2018-2029
6.5 By Type, Global Lesinurad Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Lesinurad Segment by Application
7.1.1 Research Institute
7.1.2 Pharmaceutical
7.1.3 Others
7.2 By Application, Global Lesinurad Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Lesinurad Consumption Value, 2018-2029
7.4 By Application, Global Lesinurad Sales Quantity, 2018-2029
7.5 By Application, Global Lesinurad Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Lesinurad Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Lesinurad Consumption Value, 2018-2029
8.3 By Region, Global Lesinurad Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Lesinurad & Forecasts, 2018-2029
8.4.2 By Country, North America Lesinurad Market Size Market Share
8.5 Europe
8.5.1 Europe Lesinurad Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Lesinurad Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Lesinurad Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Lesinurad Market Size Market Share
8.7 South America
8.7.1 South America Lesinurad Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Lesinurad Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Lesinurad Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Lesinurad Consumption Value, 2018-2029
9.3 By Country, Global Lesinurad Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Lesinurad Market Size, 2018-2029
9.4.2 By Type, U.S. Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Lesinurad Market Size, 2018-2029
9.5.2 By Type, Europe Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Lesinurad Market Size, 2018-2029
9.6.2 By Type, China Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Lesinurad Market Size, 2018-2029
9.7.2 By Type, Japan Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Lesinurad Market Size, 2018-2029
9.8.2 By Type, South Korea Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Lesinurad Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Lesinurad Market Size, 2018-2029
9.10.2 By Type, India Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Lesinurad Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Lesinurad Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Lesinurad Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AbMole BioScience
10.1.1 AbMole BioScience Company Information, Head Office, Market Area, and Industry Position
10.1.2 AbMole BioScience Lesinurad Models, Specifications, and Application
10.1.3 AbMole BioScience Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AbMole BioScience Company Profile and Main Business
10.1.5 AbMole BioScience Recent Developments
10.2 Ausun Pharmaceutical
10.2.1 Ausun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.2.2 Ausun Pharmaceutical Lesinurad Models, Specifications, and Application
10.2.3 Ausun Pharmaceutical Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Ausun Pharmaceutical Company Profile and Main Business
10.2.5 Ausun Pharmaceutical Recent Developments
10.3 Cayman Chemical
10.3.1 Cayman Chemical Company Information, Head Office, Market Area, and Industry Position
10.3.2 Cayman Chemical Lesinurad Models, Specifications, and Application
10.3.3 Cayman Chemical Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Cayman Chemical Company Profile and Main Business
10.3.5 Cayman Chemical Recent Developments
10.4 MedKoo Biosciences
10.4.1 MedKoo Biosciences Company Information, Head Office, Market Area, and Industry Position
10.4.2 MedKoo Biosciences Lesinurad Models, Specifications, and Application
10.4.3 MedKoo Biosciences Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 MedKoo Biosciences Company Profile and Main Business
10.4.5 MedKoo Biosciences Recent Developments
10.5 Clearsynth
10.5.1 Clearsynth Company Information, Head Office, Market Area, and Industry Position
10.5.2 Clearsynth Lesinurad Models, Specifications, and Application
10.5.3 Clearsynth Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Clearsynth Company Profile and Main Business
10.5.5 Clearsynth Recent Developments
10.6 Target Mol
10.6.1 Target Mol Company Information, Head Office, Market Area, and Industry Position
10.6.2 Target Mol Lesinurad Models, Specifications, and Application
10.6.3 Target Mol Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Target Mol Company Profile and Main Business
10.6.5 Target Mol Recent Developments
10.7 UQUIFA
10.7.1 UQUIFA Company Information, Head Office, Market Area, and Industry Position
10.7.2 UQUIFA Lesinurad Models, Specifications, and Application
10.7.3 UQUIFA Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 UQUIFA Company Profile and Main Business
10.7.5 UQUIFA Recent Developments
10.8 MSN Labs
10.8.1 MSN Labs Company Information, Head Office, Market Area, and Industry Position
10.8.2 MSN Labs Lesinurad Models, Specifications, and Application
10.8.3 MSN Labs Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 MSN Labs Company Profile and Main Business
10.8.5 MSN Labs Recent Developments
10.9 CHEMO
10.9.1 CHEMO Company Information, Head Office, Market Area, and Industry Position
10.9.2 CHEMO Lesinurad Models, Specifications, and Application
10.9.3 CHEMO Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 CHEMO Company Profile and Main Business
10.9.5 CHEMO Recent Developments
10.10 Nifty Labs
10.10.1 Nifty Labs Company Information, Head Office, Market Area, and Industry Position
10.10.2 Nifty Labs Lesinurad Models, Specifications, and Application
10.10.3 Nifty Labs Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Nifty Labs Company Profile and Main Business
10.10.5 Nifty Labs Recent Developments
10.11 Manus Aktteva Biopharma LLP
10.11.1 Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area, and Industry Position
10.11.2 Manus Aktteva Biopharma LLP Lesinurad Models, Specifications, and Application
10.11.3 Manus Aktteva Biopharma LLP Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Manus Aktteva Biopharma LLP Company Profile and Main Business
10.11.5 Manus Aktteva Biopharma LLP Recent Developments
10.12 Vcare Pharmatech
10.12.1 Vcare Pharmatech Company Information, Head Office, Market Area, and Industry Position
10.12.2 Vcare Pharmatech Lesinurad Models, Specifications, and Application
10.12.3 Vcare Pharmatech Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Vcare Pharmatech Company Profile and Main Business
10.12.5 Vcare Pharmatech Recent Developments
10.13 Meso Chem
10.13.1 Meso Chem Company Information, Head Office, Market Area, and Industry Position
10.13.2 Meso Chem Lesinurad Models, Specifications, and Application
10.13.3 Meso Chem Lesinurad Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Meso Chem Company Profile and Main Business
10.13.5 Meso Chem Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Lesinurad Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lesinurad Market Restraints
Table 3. Lesinurad Market Trends
Table 4. Lesinurad Industry Policy
Table 5. Global Lesinurad Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Lesinurad Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Lesinurad Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 8. Global Lesinurad Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Lesinurad Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)
Table 10. Global Lesinurad Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lesinurad Mergers & Acquisitions, Expansion Plans
Table 12. Global Lesinurad Manufacturers Product Type
Table 13. Head Office and Lesinurad Production Site of Key Manufacturer
Table 14. Lesinurad Capacity of Major Manufacturers and Future Plan
Table 15. China Lesinurad Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Lesinurad Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 17. China Lesinurad Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Lesinurad Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 19. Global Lesinurad Production by Region, 2018-2023, (Tons)
Table 20. Global Lesinurad Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of Lesinurad Upstream (Raw Materials)
Table 22. Global Lesinurad Typical Customers
Table 23. Lesinurad Typical Distributors
Table 24. By Type, Global Lesinurad Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Lesinurad Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Lesinurad Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Lesinurad Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Lesinurad Sales Quantity, 2018-2029, (Tons)
Table 29. By Country, Global Lesinurad Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Lesinurad Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Lesinurad Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Lesinurad Sales Quantity, 2018-2029, (Tons)
Table 33. By Country, Global Lesinurad Sales Quantity Market Share, 2018-2029
Table 34. AbMole BioScience Company Information, Head Office, Market Area, and Industry Position
Table 35. AbMole BioScience Lesinurad Models, Specifications, and Application
Table 36. AbMole BioScience Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 37. AbMole BioScience Company Profile and Main Business
Table 38. AbMole BioScience Recent Developments
Table 39. Ausun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 40. Ausun Pharmaceutical Lesinurad Models, Specifications, and Application
Table 41. Ausun Pharmaceutical Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Ausun Pharmaceutical Company Profile and Main Business
Table 43. Ausun Pharmaceutical Recent Developments
Table 44. Cayman Chemical Company Information, Head Office, Market Area, and Industry Position
Table 45. Cayman Chemical Lesinurad Models, Specifications, and Application
Table 46. Cayman Chemical Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Cayman Chemical Company Profile and Main Business
Table 48. Cayman Chemical Recent Developments
Table 49. MedKoo Biosciences Company Information, Head Office, Market Area, and Industry Position
Table 50. MedKoo Biosciences Lesinurad Models, Specifications, and Application
Table 51. MedKoo Biosciences Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. MedKoo Biosciences Company Profile and Main Business
Table 53. MedKoo Biosciences Recent Developments
Table 54. Clearsynth Company Information, Head Office, Market Area, and Industry Position
Table 55. Clearsynth Lesinurad Models, Specifications, and Application
Table 56. Clearsynth Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Clearsynth Company Profile and Main Business
Table 58. Clearsynth Recent Developments
Table 59. Target Mol Company Information, Head Office, Market Area, and Industry Position
Table 60. Target Mol Lesinurad Models, Specifications, and Application
Table 61. Target Mol Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. Target Mol Company Profile and Main Business
Table 63. Target Mol Recent Developments
Table 64. UQUIFA Company Information, Head Office, Market Area, and Industry Position
Table 65. UQUIFA Lesinurad Models, Specifications, and Application
Table 66. UQUIFA Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. UQUIFA Company Profile and Main Business
Table 68. UQUIFA Recent Developments
Table 69. MSN Labs Company Information, Head Office, Market Area, and Industry Position
Table 70. MSN Labs Lesinurad Models, Specifications, and Application
Table 71. MSN Labs Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. MSN Labs Company Profile and Main Business
Table 73. MSN Labs Recent Developments
Table 74. CHEMO Company Information, Head Office, Market Area, and Industry Position
Table 75. CHEMO Lesinurad Models, Specifications, and Application
Table 76. CHEMO Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. CHEMO Company Profile and Main Business
Table 78. CHEMO Recent Developments
Table 79. Nifty Labs Company Information, Head Office, Market Area, and Industry Position
Table 80. Nifty Labs Lesinurad Models, Specifications, and Application
Table 81. Nifty Labs Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Nifty Labs Company Profile and Main Business
Table 83. Nifty Labs Recent Developments
Table 84. Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area, and Industry Position
Table 85. Manus Aktteva Biopharma LLP Lesinurad Models, Specifications, and Application
Table 86. Manus Aktteva Biopharma LLP Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 87. Manus Aktteva Biopharma LLP Company Profile and Main Business
Table 88. Manus Aktteva Biopharma LLP Recent Developments
Table 89. Vcare Pharmatech Company Information, Head Office, Market Area, and Industry Position
Table 90. Vcare Pharmatech Lesinurad Models, Specifications, and Application
Table 91. Vcare Pharmatech Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 92. Vcare Pharmatech Company Profile and Main Business
Table 93. Vcare Pharmatech Recent Developments
Table 94. Meso Chem Company Information, Head Office, Market Area, and Industry Position
Table 95. Meso Chem Lesinurad Models, Specifications, and Application
Table 96. Meso Chem Lesinurad Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 97. Meso Chem Company Profile and Main Business
Table 98. Meso Chem Recent Developments
List of Figures
Figure 1. Lesinurad Picture
Figure 2. Global Lesinurad Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Lesinurad Sales Quantity, (Tons) & (2018-2029)
Figure 4. Global Lesinurad Average Selling Price (ASP), (2018-2029) & (US$/Ton)
Figure 5. China Lesinurad Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Lesinurad Sales Quantity (Tons) & (2018-2029)
Figure 7. China Lesinurad Average Selling Price (ASP), (US$/Ton) & (2018-2029)
Figure 8. By Consumption Value, China Lesinurad Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Lesinurad Market Share of Global, 2018-2029
Figure 10. Global Lesinurad Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Lesinurad Key Participants, Market Share, 2022
Figure 12. Global Lesinurad Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Lesinurad Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Lesinurad Production Market Share & Forecast by Region, 2018-2029
Figure 15. Lesinurad Industry Chain
Figure 16. Lesinurad Procurement Model
Figure 17. Lesinurad Sales Model
Figure 18. Lesinurad Sales Channels, Direct Sales, and Distribution
Figure 19. Purity ≥ 98 %
Figure 20. Purity ≥ 99 %
Figure 21. By Type, Global Lesinurad Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Lesinurad Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 24. By Type, Global Lesinurad Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Lesinurad Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 26. Research Institute
Figure 27. Pharmaceutical
Figure 28. Others
Figure 29. By Application, Global Lesinurad Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Lesinurad Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 32. By Application, Global Lesinurad Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Lesinurad Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 34. By Region, Global Lesinurad Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Lesinurad Sales Quantity Market Share, 2018-2029
Figure 36. North America Lesinurad Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Lesinurad Consumption Value Market Share, 2022
Figure 38. Europe Lesinurad Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Lesinurad Consumption Value Market Share, 2022
Figure 40. Asia Pacific Lesinurad Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Lesinurad Consumption Value Market Share, 2022
Figure 42. South America Lesinurad Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Lesinurad Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Lesinurad Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 46. By Type, U.S. Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 49. By Type, Europe Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 52. By Type, China Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 55. By Type, Japan Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 58. By Type, South Korea Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 61. By Type, Southeast Asia Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 64. By Type, India Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Lesinurad Sales Quantity, 2018-2029, (Tons)
Figure 67. By Type, Middle East & Africa Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Lesinurad Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|